Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000995263 | SCV001149351 | likely benign | not provided | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001427782 | SCV001630467 | likely benign | Focal segmental glomerulosclerosis 5; Charcot-Marie-Tooth disease dominant intermediate E | 2023-03-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002445149 | SCV002735588 | benign | Inborn genetic diseases | 2020-03-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |